Pfizer share price: what to expect from Q1 result

In this article we find out what we can expect from the upcoming Pfizer results, how they could affect the Pfizer share price as well as how to trade the  earnings.

When is Pfizer earnings date?

The Pfizer earnings release date is scheduled for the 4 May. The results will cover the groups quarter one (Q1) financial year 2021 (FY21) earnings (January to March 2021).

Pfizer results preview: what does the Street expect?

Pfizer, the research based global biopharmaceutical company, is expected to see low double digit revenue growth for Q1 2021 when compared to the prior year’s comparative period (Q1 2020), although earnings per share for the period are expected to be relatively flat against the comparative due to an increased cost base.

The average estimates for the upcoming results are as follows:

How to trade Pfizer Q1 results

The two graphics below provide traders with both a retail short-term view on the stock, as well as an institutional longer-term view on the Pfizer share price, as to how market participants are positioned ahead of the Q1 earnings release.

A Refinitiv poll of 22 analysts maintain a long-term average rating of ‘hold’ for Pfizer (as of 3 May), with two of these analysts recommending a strong buy, five recommending a buy, 15 hold, zero sell and zero strong sell recommendations on the stock.

From a retail trader perspective (as of 3 May), 99% of IG clients with open positions on the Pfizer expect the share price to rise over the near term, while 1% of IG clients with open positions expect the Pfizer price to fall.

Pfizer share price: technical analysis

The Pfizer share price is currently testing resistance of the $33.40 to $39.30 range within which it currently trades.

For a bullish trading scenario, traders will want to see a confirmed (with a daily close) break of the $39.30 level, before targeting a move to the near term high at $42.90. In this scenario, a close below the dotted trend line may be used as a stop loss consideration.

For a bearish trading scenario, a close below the dotted trend line support could indicate that the price is now looking to return to range support at $33.40. In this scenario, $33.40 becomes the downside target, while a close above range resistance at $39.30 could be used as a stop loss consideration for the trade.

In summary

  • Pfizer Q1 FY21 results are scheduled for release on the 4 May
  • Group revenue for the quarter is expected to be realized at $13.6 billion
  • EPS for the quarter is expected to be realized at $0.78
  • The majority of IG clients with open positions on Pfizer expect the price to rise in the near term
  • A technical analysis view on the Pfizer share price shows a short to medium-term rangebound price environment

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.